The pharmaceutical landscape is seeing a shift with the introduction of GLP-1 delivery devices. These cutting-edge formulations offer a promising approach to providing glucagon-like peptide-1 medication for individuals managing type 2 diabetes . Instead of daily shots , a simple patch applied to